These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3271756)

  • 21. Diabetes care and complications in a remote primary health care setting.
    Maple-Brown LJ; Brimblecombe J; Chisholm D; O'Dea K
    Diabetes Res Clin Pract; 2004 May; 64(2):77-83. PubMed ID: 15063599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term complications of type I (insulin-dependent) diabetes mellitus.
    Rosenbloom AL
    Pediatr Ann; 1983 Sep; 12(9):668-84. PubMed ID: 6355999
    [No Abstract]   [Full Text] [Related]  

  • 23. [Type-2 diabetes mellitus as a cause of disability].
    Piechota G; Małkiewicz J; Karwat ID
    Przegl Epidemiol; 2004; 58(4):677-82. PubMed ID: 15810510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients.
    Romero-Aroca P; Fernández-Balart J; Baget-Bernaldiz M; Martinez-Salcedo I; Méndez-Marín I; Salvat-Serra M; Buil-Calvo JA
    J Diabetes Complications; 2009; 23(4):229-38. PubMed ID: 18439844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe diabetic retinopathy and renal function in non-insulin-dependent (type-2) diabetes mellitus].
    Lugari R; Scoccianti L; Sborbone P; Bianco M; Dell'Anna C; Barilli LA; Gnudi A
    Minerva Endocrinol; 1995 Jun; 20(2):127-34. PubMed ID: 8531894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of some pituitary hormones in patients with non-insulin-dependent diabetes mellitus and diabetic retinopathy].
    Dundua TT; Sumbadze TsM; Dzhodzhua TD; Papava MV
    Georgian Med News; 2006 Aug; (137):68-71. PubMed ID: 16980749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of elevated serum uric acid with coronary heart disease in diabetes mellitus.
    Rathmann W; Hauner H; Dannehl K; Gries FA
    Diabete Metab; 1993; 19(1 Pt 2):159-66. PubMed ID: 8314420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Significance of changes in blood serum hexosamines in the pathogenesis of diabetic microangiopathies].
    Riabchuk OG; Starosel'tseva LK
    Sov Med; 1970 Mar; 33(3):21-4. PubMed ID: 5419171
    [No Abstract]   [Full Text] [Related]  

  • 30. [Basal membrane and diabetes mellitus].
    Masmiquel L; Burgos R; Simó R
    Med Clin (Barc); 1997 Sep; 109(8):302-10. PubMed ID: 9379754
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetic nephropathy and retinopathy.
    Jawa A; Kcomt J; Fonseca VA
    Med Clin North Am; 2004 Jul; 88(4):1001-36, xi. PubMed ID: 15308388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case from practice (311). Sensorimotor polyneuropathy and autonomous neuropathy with increased sweating in insulin-dependent diabetes mellitus II--diabetic retinopathy, nephropathy and microangiopathy].
    Thumshirn M; Berger W
    Praxis (Bern 1994); 1994 Nov; 83(45):1272-3. PubMed ID: 7973288
    [No Abstract]   [Full Text] [Related]  

  • 33. Electrocardiographic abnormalities in diabetes mellitus: association between T-wave changes and nephropathy.
    Faierman D; Bloomgarden ZT; Nechemias C; Brown WV
    Mt Sinai J Med; 1986 Apr; 53(4):254-9. PubMed ID: 3487720
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the course of development in 84 non-insulin-dependent diabetics over a 5-to-10-year period. Their therapeutic outcome].
    Roche S; Moinade S
    Sem Hop; 1983 Dec; 59(44):3029-32. PubMed ID: 6320388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
    Orchard TJ; Forrest KY; Ellis D; Becker DJ
    Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research digest: progress in microvascular complications.
    Sattar N; Preiss D
    Lancet Diabetes Endocrinol; 2018 Feb; 6(2):93. PubMed ID: 29413165
    [No Abstract]   [Full Text] [Related]  

  • 37. Complications of type 2 diabetes mellitus: a brief overview.
    Schorr AB
    J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S10-4. PubMed ID: 10659524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of overt proteinuria and coronary artery disease in patients with type 2 diabetes mellitus: the role of microalbuminuria and retinopathy.
    Kim KS; Koh JM; Song KH; Nam-Gung IS; Kim MS; Park JY; Lee KU
    Diabetes Res Clin Pract; 2004 Aug; 65(2):159-65. PubMed ID: 15223228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinopathy and nephropathy in 772 insulin-treated diabetic patients in relation to the type of diabetes.
    Schmechel H; Heinrich U
    Diabete Metab; 1993; 19(1 Pt 2):138-42. PubMed ID: 8314417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
    Faur L; Motocu M; Moldovan C; Onaca M; Muţiu G
    Rom J Morphol Embryol; 2005; 46(4):307-9. PubMed ID: 16688368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.